NCT04202055View on ClinicalTrials.gov

Immunologic Biomarker Profile of Cerebrospinal Fluid

CompletedOBSERVATIONAL
Enrollment

165

Participants

Timeline

Start Date

January 2, 2018

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2019

Conditions
Multiple SclerosisNeuromyelitis Optica
Interventions
OTHER

Biomarker analysis

Detection of biomarker in cerebrospinal fluid

Trial Locations (1)

30029

CHU de Nimes, Nîmes

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nīmes

OTHER

NCT04202055 - Immunologic Biomarker Profile of Cerebrospinal Fluid | Biotech Hunter | Biotech Hunter